EDSA
Edesa Biotech Inc
NASDAQ: EDSA · HEALTHCARE · BIOTECHNOLOGY
$18.28
+14.94% today
Updated 2026-04-30
Market cap
$64.51M
P/E ratio
—
P/S ratio
130,462.29x
EPS (TTM)
$-1.07
Dividend yield
—
52W range
$1 – $12
Volume
5.6M
Edesa Biotech Inc (EDSA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-96.40%
ROA
-55.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | — | $-73917.00 | — | — | — |
| 2010 | $854837.00 | $-589971.00 | 54.83% | -124.63% | -69.02% |
| 2011 | $697187.00 | $-7.09M | -44.74% | -1,018.37% | -1,016.39% |
| 2012 | $286054.00 | $-5.20M | -52.56% | -2,280.23% | -1,816.68% |
| 2013 | $545469.00 | $-14.89M | -5.69% | -674.37% | -2,729.12% |
| 2014 | $372132.00 | $-8.44M | -104.30% | -1,536.69% | -2,267.88% |
| 2015 | $758689.00 | $-2.84M | -10.75% | -571.85% | -374.73% |
| 2016 | $1.27M | $-5.03M | 11.31% | -385.97% | -395.23% |
| 2017 | $228287.00 | $-5.03M | -134.11% | -2,288.59% | -2,203.65% |
| 2018 | $211849.00 | $-5.04M | -110.21% | -2,397.11% | -2,378.56% |
| 2019 | $410870.00 | $-2.72M | 75.35% | -689.30% | -662.33% |
| 2020 | $328801.00 | $-6.36M | 94.65% | -1,946.72% | -1,935.59% |
| 2021 | $500.00 | $-13.34M | -23,757.60% | -4,736,266.40% | -2,668,630.00% |
| 2022 | $0.00 | $-17.55M | — | — | — |
| 2023 | $0.00 | $-8.37M | — | — | — |
| 2024 | $0.00 | $-6.17M | — | — | — |
| 2025 | $0.00 | $-7.19M | — | — | — |